# A Study of Pirtobrutinib (LY3527727) in Participants With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

> clinical trial · VERIFIED · 2026-08-06

Status: RECRUITING · Sponsor: Eli Lilly and Company · Condition: Chronic Lymphocytic Leukemia

- Company: Eli Lilly and Company
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07218341

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.